Technical Analysis Based on recent price action, SNY shows a bullish momentum with RSI(14) at 64.91 indicating strong but not overbought conditions. The MACD is positive at 1.11 with a flat histogram, suggesting continued upward momentum.
Price Levels & Support/Resistance
News Impact Recent positive catalysts include:
Next Week Price Prediction Based on technical indicators and recent news:
Trading Recommendation BUY with entry at current levels ($54.59)
The stock shows strong momentum with positive news catalysts and healthy technical indicators, suggesting continued upward movement in the coming week.
The price of SNY is predicted to go up -2.12%, based on the high correlation periods with NU. The similarity of these two price pattern on the periods is 98.26%.
SNY
NU
Year
SNY Price Forecast($)
Potential Return(%)
2025
48.320
0.350
2026
100.000
84.030
2027
110.000
102.430
2028
120.000
120.830
2029
85.000
56.420
2030
120.000
120.830
Sanofi is launching immunology drug Dupixent in several indications and the drug holds strong pricing power and major blockbuster potential across several indications.
Sanofi's strong entrenchment in rare-disease drugs should translate into steady pricing power as payers tend not to push back on pricing in these areas.
With a wide product offering in vaccines, consumer health and insulins, Sanofi is well positioned for the fast-growing emerging markets.